TriangleFOR PATIENTS · SOURCE READING
Certain factors affect prognosis (chance of recovery) and treatment options.
Source: Gestational Trophoblastic Disease Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 25, 2022 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Gestational trophoblastic disease usually can be cured. Treatment and prognosis depend on the following:
The type of GTD.
Whether the tumor has spread to the uterus, lymph nodes, or distant parts of the body.
The number of tumors and where they are in the body.
The size of the largest tumor.
The level of beta-hCG in the blood.
How soon the tumor was diagnosed after the pregnancy began.
Source links and citations
Whether GTD occurred after a molar pregnancy, miscarriage, or normal pregnancy.
Previous treatment for gestational trophoblastic neoplasia.
Treatment options also depend on whether the woman wishes to become pregnant in the future.
Preserved source evidence · Independent clinical review pending · Not medical advice